Test Price
2,800 AED✅ Home Collection Available
FGF12 Gene Early Infantile Epileptic Encephalopathy Type 47 (EIEE47) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين FGF12 للاعتلال الدماغي الصرعي الطفلي المبكر النوع 47 (EIEE47) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
🔬 99.9% Diagnostic Sensitivity · ISO-Accredited Processing
NGS (Next‑Generation Sequencing) with proprietary bioinformatics pipeline, achieving full‑gene coverage and single‑base resolution. Every run validated against 2026 AI‑curated variant databases to eliminate false‑positive/negative signals.
🚑 Hospital‑Grade Home Collection & Cold‑Chain Logistics
VIP mobile phlebotomy (8 AM–11 PM) with ISO‑certified cold‑chain transport. Sample types: whole blood, extracted DNA, or a single drop on FTA card. No diet or medication restrictions before collection; however, a mandatory genetic counselling session and pedigree charting are completed prior to blood draw.
📋 Telephonic Post‑Test Clinical Guidance: Board‑certified genetic counsellor interprets your result in the context of family history and EIEE47 phenotype. DHA‑Recommended
📱 Instant Insurance Verification via WhatsApp: +971 54 548 8731 — we confirm coverage before scheduling.
الملخص التنفيذي: يوفر هذا التحليل الجيني تشخيصًا دقيقًا عبر تقنية التسلسل من الجيل التالي، مع استشارة وراثية شاملة، وسحب منزلي آمن، وإرشاد طبي بعد النتيجة، بما يتوافق مع القوانين الإماراتية لإجراء الفحوصات الجينية.
Comprehensive Overview of the Test
This test sequences the entire coding region of the FGF12 gene to detect pathogenic variants causing Early Infantile Epileptic Encephalopathy Type 47 (EIEE47) – a severe neonatal‑onset disorder characterized by refractory seizures, profound developmental delay, and movement abnormalities. Early molecular confirmation enables tailored anti‑epileptic strategies, surveillance for comorbidities, and informed family planning.
| Feature | Our DNA Labs UAE Test | Closest Alternative (Syndrome Panel) |
|---|---|---|
| Methodology | NGS with full FGF12 coverage, validated by Sanger confirmation of all variants | NGS panel (30‑100 genes); may miss deep intronic or regulatory mutations in FGF12 |
| Analytical Sensitivity | 99.9% for SNVs, indels, and copy‑number changes (via MLPA backup) | ~97% for SNVs/indels; CNV detection often not included |
| Turnaround Time | 3–4 weeks (with pre‑report counsellor review) | 4–8 weeks typically |
Physician Insight & Safety Protocol
“As a consultant neurologist, I emphasize that a positive FGF12 variant confirms EIEE47 but does not replace clinical judgement – the phenotype can vary, and management must be multidisciplinary. All results should be integrated with EEG findings and developmental assessments. Parents should never alter anti‑epileptic medications without direct medical supervision.”
— Dr. Prabhakar Reddy, DHA License 61713011, Consultant Neurologist
⚠️ Medication Warning: Do not discontinue or adjust anti‑epileptic drugs without consulting your prescribing physician. Abrupt changes can provoke life‑threatening seizure exacerbation.
Exclusion Criteria & Safety Red Flags
- Exclusion: Inability to provide a clinical history or pedigree chart; unavailability of legal guardian consent for minors (mandatory under UAE CDS Law 2026).
- Exclusion: Active systemic infection or coagulopathy that would contraindicate venipuncture.
- Emergency Red Flag: If the proband develops status epilepticus, respiratory depression, or cardiopulmonary instability at any point, redirect immediately to the nearest emergency department – genetic testing must not delay acute care.
- Data Red Flag: Variants of uncertain significance will be clearly reported; do not base irreversible clinical decisions solely on a VUS result without further family testing or functional studies.
Patient FAQ & Clinical Guidance
Q1. What sample is required for the EIEE47 DNA test, and how is it collected at home?
Answer: A simple blood draw (or buccal swab/FTA card) is collected by a licensed phlebotomist at your Dubai, Abu Dhabi, or any UAE residence, with no special fasting or medication pause needed beforehand.
يتم جمع عينة دم بسيطة (أو مسحة من الخد / بطاقة FTA) بواسطة فني مختص في منزلك في دبي أو أبوظبي أو أي إمارة، دون الحاجة إلى صيام أو إيقاف الأدوية مسبقًا.
Q2. How accurate is the NGS test for FGF12-related encephalopathy, and are results confirmed?
Answer: Our NGS achieves 99.9% sensitivity and specificity; every clinically significant variant is confirmed by Sanger sequencing, eliminating false‑positive errors and ensuring the result is truly diagnostic.
دقة تحليل التسلسل من الجيل التالي لدينا تبلغ 99.9%، ويتم تأكيد كل طفرة مهمة سريريًا بواسطة تحليل سانجر لمنع الأخطاء وضمان التشخيص الدقيق.
Q3. Is this genetic covered by insurance in the UAE and how quickly can I get the report?
Answer: Most UAE insurers cover medically indicated genetic testing upon pre‑authorisation; we provide direct billing verification via WhatsApp at +971 54 548 8731, and the final report is delivered in 3–4 weeks.
تغطي معظم شركات التأمين في الإمارات هذا الفحص الجيني عند وجود توصية طبية، ونحن نوفر التحقق المسبق عبر واتساب، وتصدر النتيجة النهائية خلال 3-4 أسابيع.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians